Van Poznak C - Search Results

1

Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.

Van Poznak C, Reynolds EL, Estilo CL, Hu M, Schneider BP, Hertz DL, Gersch C, Thibert J, Thomas D, Banerjee M, Rae JM, Hayes DF. Van Poznak C, et al. Oral Dis. 2022 Jan;28(1):193-201. doi: 10.1111/odi.13746. Epub 2020 Dec 14. Oral Dis. 2022. PMID: 33274559 Free PMC article.

2

The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.

Van Poznak C. Van Poznak C. Cancer Invest. 2006 Feb;24(1):110-2. doi: 10.1080/07357900500449652. Cancer Invest. 2006. PMID: 16467002

3

Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

Van Poznak CH, Hayes DF. Van Poznak CH, et al. J Natl Cancer Inst. 2006 Sep 20;98(18):1261-3. doi: 10.1093/jnci/djj387. J Natl Cancer Inst. 2006. PMID: 16985239 No abstract available.

4

Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.

Van Poznak C, Estilo C. Van Poznak C, et al. Oncology (Williston Park). 2006 Aug;20(9):1053-62; discussion 1065-6. Oncology (Williston Park). 2006. PMID: 16986349 Free article. Review.

5

Bisphosphonates for breast cancer: questions answered, questions remaining.

Layman R, Olson K, Van Poznak C. Layman R, et al. Among authors: van poznak c. Hematol Oncol Clin North Am. 2007 Apr;21(2):341-67. doi: 10.1016/j.hoc.2007.03.004. Hematol Oncol Clin North Am. 2007. PMID: 17512453 Review.

6

Significance and impact of bisphosphonate-induced acute phase responses.

Olson K, Van Poznak C. Olson K, et al. Among authors: van poznak c. J Oncol Pharm Pract. 2007 Dec;13(4):223-9. doi: 10.1177/1078155207080806. J Oncol Pharm Pract. 2007. PMID: 18045781 Review.

7

Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.

Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM. Estilo CL, et al. Among authors: van poznak ch. Oncologist. 2008 Aug;13(8):911-20. doi: 10.1634/theoncologist.2008-0091. Epub 2008 Aug 11. Oncologist. 2008. PMID: 18695259 Free article.

8

Osteonecrosis of the jaw and bevacizumab therapy.

Van Poznak C. Van Poznak C. Breast Cancer Res Treat. 2010 Jul;122(1):189-91. doi: 10.1007/s10549-010-0933-9. Epub 2010 May 13. Breast Cancer Res Treat. 2010. PMID: 20464477 Free PMC article. No abstract available.

9

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.

Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C, Storniolo AM, Stearns V, Hayes DF. Henry NL, et al. Among authors: van poznak c. Cancer. 2010 Sep 15;116(18):4360-7. doi: 10.1002/cncr.25385. Cancer. 2010. PMID: 20549827 Free PMC article.

10

Updates on osteonecrosis of the jaw.

Yamashita J, McCauley LK, Van Poznak C. Yamashita J, et al. Among authors: van poznak c. Curr Opin Support Palliat Care. 2010 Sep;4(3):200-6. doi: 10.1097/SPC.0b013e32833d303b. Curr Opin Support Palliat Care. 2010. PMID: 20657284 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters